Passage Bio (PASG) Stock Price, Quote, News & History | Benzinga

Passage Bio Inc (PASG) Stock Price, Quote, News & History

PASGNASDAQ

Trade with Public

Trade with Public

$4.50

-0.33-6.83%

At close: Aug 25, 5:00 PM EST

$4.50

-0.33-6.83%

Pre-Market: 4:09 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

-

Close

$4.50

Volume / Avg.

502.00 / 67.41K

Day Range

- - -

52 Wk Range

3.29 - 20.00

Market Cap

$14.48M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

5.31%

Days to Cover

13.12

Recent Passage Bio Inc News

This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday

Wall Street analysts changed outlook for top names, including downgrading Mohawk Industries and Passage Bio. See analyst ratings for these stocks.

Avi Kapoor

Crude Oil Surges Over 6%; Investar Holding Shares Gain Following Q1 Earnings

US stocks down at midday, Dow down 0.2%, NASDAQ down 0.52%. Energy up 1.1%, consumer discretionary down 1.2%. Investar beats earnings.

Avi Kapoor

US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results

US stocks mixed, energy shares climb. Cleveland-Cliffs falls 6% after reporting Q1 results. Enveric Biosciences, Fitness Champs, Clearmind Medicine surge.

Avi Kapoor

Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket

Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results.

Avi Kapoor

Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities

Passage Bio Inc (NASDAQ: PASG) announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT-D clinical trial evaluating PBFT02, an adeno-associated virus (AAV)-delivery gene therapy for frontotemporal dementia (FTD) with

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-33.50M

Investing Cash Flow (TTM)

20.00K

Financing Cash Flow (TTM)

9.00K

Free Cash Flow (TTM)

-33.50M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-33.47M

Analyst Trends and Forecast

2

Mar

1

2

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$9.51M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.29

Earnings Yield % (TTM)

-248.79%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.38

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$24.16M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$4.50

Volume / Avg.

502.00 / 67.41K

Day Range

- - -

52 Wk Range

3.29 - 20.00

Market Cap

$14.48M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

5.31%

Days to Cover

13.12

About

Sector

Health Care

Industry

Biotechnology

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to targ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Passage Bio (PASG) stock?

A

You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Passage Bio (PASG) competitors?

A

There are no as such competitors for Passage Bio.

Q

What is the forecast, or price target, for Passage Bio (PASG) stock?

A

Passage Bio has a consensus price target of $12.00.

Q

What is the current price for Passage Bio (PASG)?

A

The stock price for Passage Bio (NASDAQ: PASG) is $4.5 last updated August 27, 2026 at 4:00 AM EDT.

Q

Does Passage Bio (PASG) pay a dividend?

A

There are no upcoming dividends for Passage Bio.

Q

When is Passage Bio (NASDAQ:PASG) reporting earnings?

A

Passage Bio does not have any upcoming earnings scheduled.

Q

Is Passage Bio (PASG) going to split?

A

There is no upcoming split for Passage Bio.

Q

What sector and industry does Passage Bio (PASG) operate in?

A

Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.